Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by mcarter4on Sep 08, 2004 10:31am
481 Views
Post# 7895159

Is TTH still on schedule

Is TTH still on schedule I believe this is from an analysts list of event for TTH to demonstrate progression. I wonder if TTH is still on schedule or does delay in Novo closing indicate slowness in other areas, which could account for share price being stuck. Q3 2004 Expect IND submission for Phase I IET study for hepatitis C (July) Q3 2004 Expect IND submission for INT program Q3 2004 Commence Phase II INT (EGF/gastrin) study (August) Q4 2004 Commence Phase II INT-2 (GLP-1/gastrin) study (November) Q4 2004 Commence Phase I IET hepatitis C study Q4 2004 Identify lead compound for peripheral restenosis human testing
Bullboard Posts